The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.
The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...
Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback